JP2643260B2 - Syrup - Google Patents

Syrup

Info

Publication number
JP2643260B2
JP2643260B2 JP63069037A JP6903788A JP2643260B2 JP 2643260 B2 JP2643260 B2 JP 2643260B2 JP 63069037 A JP63069037 A JP 63069037A JP 6903788 A JP6903788 A JP 6903788A JP 2643260 B2 JP2643260 B2 JP 2643260B2
Authority
JP
Japan
Prior art keywords
syrup
cimetidine
acid
added
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63069037A
Other languages
Japanese (ja)
Other versions
JPH01242524A (en
Inventor
茂雄 中西
美智代 深江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP63069037A priority Critical patent/JP2643260B2/en
Publication of JPH01242524A publication Critical patent/JPH01242524A/en
Application granted granted Critical
Publication of JP2643260B2 publication Critical patent/JP2643260B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 [産業上の利用分野] この発明はシメチジンのシロップ剤、さらに詳しく
は、シメチジンおよびグリチルリチン酸またはその塩を
含有する溶解シロップ剤に関するものであり、医療の分
野で利用される。
The present invention relates to a syrup of cimetidine, and more particularly to a dissolved syrup containing cimetidine and glycyrrhizic acid or a salt thereof, and is used in the medical field. You.

[従来技術] 従来、シロップ剤を製造する際の甘味剤としては、シ
ョ糖、D−ソルビトール、サッカリンナトリウムなどが
汎用されている。
[Prior Art] Conventionally, sucrose, D-sorbitol, saccharin sodium and the like have been widely used as sweeteners for producing syrups.

[発明が解決しようとする問題点] シメチジンは下記の化学構造を有する抗潰瘍剤であ
り、その優れた薬効のため広く用いられているが、強い
苦味を有するために、これを内服用の液剤とする場合に
は、その苦味を防止することが必要である。
[Problems to be Solved by the Invention] Cimetidine is an anti-ulcer agent having the following chemical structure, and is widely used for its excellent medicinal effect. However, since it has strong bitterness, it is used as a liquid preparation for internal use. If so, it is necessary to prevent the bitterness.

そのためにはシロップ剤とすることが最も好ましい
が、従来シロップ剤を製造するために用いられている前
記の甘味剤を添加するだけでは、それらをシロップ剤に
添加し得る最大量を加えても、甘味が持続せず、後にシ
メチジンの苦味が残るためシロップ剤として満足できる
ものではなかった。
For that purpose, it is most preferable to use a syrup, but by simply adding the above-mentioned sweeteners conventionally used for producing a syrup, even if the maximum amount that can be added to the syrup is added, The sweetness did not last, and the bitterness of cimetidine remained, which was not satisfactory as a syrup.

[問題点を解決するための手段] この発明の発明者らは、上記の問題点を解決するため
に鋭意検討した結果、従来より食品などの甘味剤として
用いられているグリチルリチン酸またはその塩を加えて
溶解シロップ剤を調製すると、シメチジンの苦味を防止
でき、甘味が持続することを見出してこの発明を完成し
た。
[Means for Solving the Problems] The inventors of the present invention have conducted intensive studies to solve the above problems, and as a result, have found that glycyrrhizic acid or a salt thereof, which has been conventionally used as a sweetener for foods and the like, has been developed. In addition, when a dissolved syrup was prepared, it was found that the bitterness of cimetidine could be prevented and the sweetness was maintained, and the present invention was completed.

この発明で用いられるグリチルリチン酸の塩として
は、ナトリウム塩、カリウム塩などのアルカリ金属塩、
アンモニウム塩などが挙げられる。
The salts of glycyrrhizic acid used in the present invention include sodium salts, alkali metal salts such as potassium salts,
Ammonium salts and the like.

グリチルリチン酸およびその塩はそれぞれ単独で用い
てもよく、また両者を組み合わせて用いてもよく、ある
いは従来の甘味剤と併用してもよい。
Glycyrrhizic acid and its salts may be used alone or in combination, or may be used in combination with a conventional sweetener.

溶解シロップ剤中のグリチルリチン酸またはその塩の
添加量は、シメチジンの配合量によって適宜決めること
ができるが、従来の甘味剤を併用する場合、通常0.05〜
1%程度が好ましい。
The amount of glycyrrhizic acid or a salt thereof in the dissolving syrup can be determined as appropriate depending on the amount of cimetidine.
About 1% is preferable.

グリチルリチン酸またはその塩と併用される甘味剤と
しては、例えばショ糖、ブドウ糖、果糖、麦芽糖、乳糖
などの糖類、D−ソルビトール、マンニトール、キシリ
トールなどの糖アルコール類、サッカリンナトリウムな
どが挙げられ、これらの甘味剤は2種以上組み合わせて
用いてもよい。これらの甘味剤の総添加量は、シメチジ
ンの配合量によって適宜決めることができるが、通常20
〜60%程度が好ましい。
Examples of the sweetener used in combination with glycyrrhizic acid or a salt thereof include sugars such as sucrose, glucose, fructose, maltose and lactose, sugar alcohols such as D-sorbitol, mannitol and xylitol, and saccharin sodium. Two or more sweeteners may be used in combination. The total amount of these sweeteners can be appropriately determined depending on the amount of cimetidine, but usually 20
About 60% is preferable.

この発明の溶解シロップ剤には、甘味剤のほかに例え
ば酸味剤(例えばクエン酸、酒石酸、リンゴ酸、乳酸な
どの有機酸またはそのアルカリ金属塩など)、香料(例
えばストロベリーフレーバー、オレンジフレーバー、バ
ニラフレーバーなどの天然または合成フレーバーな
ど)、着色剤(黄色5号などの合成色素、カラメルなど
の天然色素など)、防腐剤(例えば安息香酸、安息香酸
ナトリウム、パラベン類など)、増粘剤(メチルセルロ
ースなど)、可溶化剤、安定化剤などシロップ剤に通常
用いられる添加剤を適宜加えてもよい。
The dissolved syrup of the present invention includes, in addition to the sweeteners, for example, sour agents (eg, organic acids such as citric acid, tartaric acid, malic acid, and lactic acid or alkali metal salts thereof), and flavors (eg, strawberry flavor, orange flavor, vanilla). Natural or synthetic flavors such as flavors), coloring agents (synthetic pigments such as yellow No. 5, natural pigments such as caramel), preservatives (eg, benzoic acid, sodium benzoate, parabens, etc.), thickeners (methylcellulose) Etc.), additives usually used in syrups such as solubilizers and stabilizers may be appropriately added.

この発明の溶解シロップ剤は、常法により製造するこ
とができるが、その一例を示せば、まず精製水にシメチ
ジンを加え、次いで塩酸を加えてシメチジンを溶解した
のち、グリチルリチン酸およびその塩などからなる甘味
剤ならびにその他の添加剤を適宜加えて撹拌することに
より製造することができる。
The dissolving syrup of the present invention can be produced by a conventional method. For example, cimetidine is first added to purified water, then hydrochloric acid is added to dissolve cimetidine, and then glycyrrhizic acid and its salt are used. It can be produced by appropriately adding a sweetener and other additives and stirring.

[効果] 以下、この発明の効果を試験例により説明する。[Effects] The effects of the present invention will be described below with reference to test examples.

官能試験 5名のパネル員により、一対比較法の官能試験で、こ
の発明による後記実施例1のシロップ剤と、対照の後記
参考例1のシロップ剤の味を比較した。
Sensory Test The taste of the syrup of Example 1 described later and the syrup of Reference Example 1 described later were compared by a sensory test of a paired comparison method by five panel members.

結果 対照のシロップ剤については5名全員が、最初甘みを
感じたもののその甘味は持続せず、すぐに苦味を感じた
のに対して、この発明のシロップ剤については、5名全
員が、甘味を持続して感じ、苦味はほとんど感じなかっ
た。
Results For the control syrup, all five felt sweet at first, but the sweetness did not last and immediately felt bitter, whereas all of the five syrups of the present invention showed sweetness. And felt little bitterness.

参考例1 精製水(40ml)にシメチジン(2.0g)および特級塩酸
(0.638ml)を加えてシメチジンを溶解した後、ショ糖
(30g)、D−ソルビトール(20g)、サッカリンナトリ
ウム(0.3g)、クエン酸ナトリウム(0.3g)、安息香酸
ナトリウム(0.2g)およびストロベリーフレーバー(0.
1ml)を加えて撹拌し、精製水で全量を100mlにしてシロ
ップ剤を得る。
Reference Example 1 Cimetidine (2.0 g) and special grade hydrochloric acid (0.638 ml) were added to purified water (40 ml) to dissolve cimetidine, and then sucrose (30 g), D-sorbitol (20 g), saccharin sodium (0.3 g), citrate Sodium silicate (0.3g), sodium benzoate (0.2g) and strawberry flavor (0.
1 ml), and the mixture is stirred. The total amount is made up to 100 ml with purified water to obtain a syrup.

[実施例] 以下、この発明を実施例により説明する。EXAMPLES Hereinafter, the present invention will be described with reference to examples.

実施例1 精製水(40ml)にシメチジン(2.0g)および特級塩酸
(0.638ml)を加えてシメチジンを溶解した後、ショ糖
(30g)、D−ソルビトール(20g)、サッカリンナトリ
ウム(0.3g)、グリチルリチン酸ジカリウム塩(0.18
g)、クエン酸ナトリウム(0.3g)、安息香酸ナトリウ
ム(0.2g)およびストロベリーフレーバー(0.1ml)を
加えて撹拌し、精製水で含量を100mlにして、溶解シロ
ップ剤を得る。
Example 1 Cimetidine (2.0 g) and special grade hydrochloric acid (0.638 ml) were added to purified water (40 ml) to dissolve cimetidine, and then sucrose (30 g), D-sorbitol (20 g), saccharin sodium (0.3 g), and glycyrrhizin Dipotassium acid salt (0.18
g), sodium citrate (0.3 g), sodium benzoate (0.2 g) and strawberry flavor (0.1 ml) are added and stirred, and the content is adjusted to 100 ml with purified water to obtain a dissolved syrup.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】シメチジンおよびグリチルリチン酸または
その塩を含有することを特徴とする溶解シロップ剤。
1. A dissolved syrup containing cimetidine and glycyrrhizic acid or a salt thereof.
JP63069037A 1988-03-22 1988-03-22 Syrup Expired - Lifetime JP2643260B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63069037A JP2643260B2 (en) 1988-03-22 1988-03-22 Syrup

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63069037A JP2643260B2 (en) 1988-03-22 1988-03-22 Syrup

Publications (2)

Publication Number Publication Date
JPH01242524A JPH01242524A (en) 1989-09-27
JP2643260B2 true JP2643260B2 (en) 1997-08-20

Family

ID=13390982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63069037A Expired - Lifetime JP2643260B2 (en) 1988-03-22 1988-03-22 Syrup

Country Status (1)

Country Link
JP (1) JP2643260B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2224634T3 (en) 1998-04-29 2005-03-01 Sumitomo Pharmaceuticals Company, Limited ORAL FORMULATION THAT INCLUDES BIGUANIDA AND AN ORGANIC ACID.
WO1999059588A1 (en) * 1998-05-21 1999-11-25 Sumitomo Pharmaceuticals Co., Ltd. Medicinal composition reduced in bitterness

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409758A1 (en) * 1977-11-25 1979-06-22 Macandrews & Forbes Co Sweetener for food and drinks - contains lactose and small quantities of ammonium glycyrrhizic acid, saccharin and a nucleotide
ATE23659T1 (en) * 1983-07-13 1986-12-15 Gen Foods Corp SWEETENER COMPOSITION AND METHODS OF ALTERING THE SWEETNESS PERCEPTION OF A FOOD.
ZA855107B (en) * 1983-07-13 1985-01-14
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine

Also Published As

Publication number Publication date
JPH01242524A (en) 1989-09-27

Similar Documents

Publication Publication Date Title
JPS6351325A (en) Stabilized liquid analgesic composition
JPS6361909B2 (en)
JPH05981B2 (en)
EP0405930A2 (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
JPH0782150A (en) Liquid-dosage type medicine containing ursodeoxycholic acid
JPH10298110A (en) Liquid antacid preparations
NO320296B1 (en) Oral suspension
JP2643260B2 (en) Syrup
JP4190769B2 (en) Oral liquid composition
JP3805646B2 (en) Pharmaceutical solution
JP4843837B2 (en) Thiamine derivative-containing composition
JPH0813737B2 (en) Syrup
JPH10273435A (en) Internal liquid preparation
JPH02212A (en) Aqueous drug preparation for oral administration
JP2687401B2 (en) Suspension for internal use
JP3770515B2 (en) Oral concealment agent for drug bitterness
US6930119B2 (en) Liquid pharmaceutical composition
JP2735122B2 (en) Liquid syrup preparation of mequitazine
JP2915252B2 (en) Method for producing a formulation with improved solubility
JPH11139992A (en) Drinking liquid composition
KR100374142B1 (en) Alternative sweetener
JPH1036252A (en) Belladonna (total) alkaloid-containing oral liquid
US20060100271A1 (en) Stabilized aqueous ranitidine compositions
JP2000175650A (en) Sweetener enhancer
WO2006118562A1 (en) Purgative composition and uses thereof

Legal Events

Date Code Title Description
S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080502

Year of fee payment: 11